Biomonitoring California Scientific Guidance Panel Meeting, December 2007

Agenda

♦ Convening the Meeting
Convener: Joan Denton, Ph.D., Director, Cal/EPA Office of Environmental Health Hazard Assessment (OEHHA)

Swearing in of Panel Members

Panel Member Introductions

Welcome
The Honorable Don Perata, Senate President Pro Tem
Mark Horton, M.D., Director, California Department of Public Health (CDPH)
Maureen Gorsen, Director, Cal/EPA Department of Toxic Substances Control (DTSC)

Meeting Overview
George Alexeeff, Ph.D., OEHHA Deputy Director for Scientific Affairs     

♦ Panel Orientation and Meeting Conduct

California’s Open Meeting and Conflict of Interest Laws
Carol Monahan-Cummings, Chief Counsel, OEHHA

Overview of SB 1379 Legislation
Michael Lipsett, M.D., CECBP Lead and Chief, CDPH Exposure Assessment Section

Role of Panel; Public Participation and Environmental Justice Elements at Panel Meetings
Lauren Zeise, Ph.D., OEHHA, Chief, Reproductive and Cancer Hazard Assessment Branch (RCHAB)

Public Input

♦ Considerations for Design of Biomonitoring Programs

Reflections on Establishing a Biomonitoring Program at the CDC
Richard Jackson, M.D., M.P.H., University of California at Berkeley and CECBP Panel member

National Academy of Sciences (NAS) Perspective on Biomonitoring Programs
Gary Ginsberg, Ph.D., Member, NAS Committee on Human Biomonitoring for Environmental Toxicants

Public Input

♦ CECBP Program in Brief

CECBP Program Overview

• Michael Lipsett, M.D., CECBP Lead and Chief, CDPH Exposure Assessment Section
• Peter Flessel, Ph.D., Chief, CDPH Environmental Health Laboratory Branch
• Myrto Petreas, Ph.D., Chief, DTSC Environmental Chemistry Branch
• Lauren Zeise, Ph.D., Chief, OEHHA RCHAB

Planning for Chemical Selection
Martha Sandy, Ph.D., OEHHA, Chief, RCHAB Cancer Toxicology and Epidemiology Section

Public Input

♦ Summary of Action Items and Advice

♦ Meeting Adjourned